Biofrontera AG BFRA
2.67 +2.67
Day range unavailable
52-week range unavailable
News
globenewswire.com Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update Woburn, MA, May 14, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy…
globenewswire.com Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of…
investorplace.com Why Is Biofrontera (BFRI) Stock Down Today? Biofrontera (NASDAQ: BFRI ) stock is on the move Friday alongside heavy trading of the biopharmaceutical company's shares. This has more than 4.3 million shares of BFRI stock changing hands as of…
investorplace.com BFRI Stock Earnings: Biofrontera Misses EPS, Revenue Estimates Biofrontera (NASDAQ: BFRI ) reported results for the first quarter of 2023. Biofrontera posted a loss per share of 28 cents.
seekingalpha.com Biofrontera AG (BFAGY) Management on Q1 2022 Results - Earnings Call Transcript Biofrontera AG (OTC:BFAGY) Q1 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Anke zur Mühlen - Corporate Communications & Investor Relations Ludwig Lutter - Chief…
benzinga.com Why Biofrontera Stock Is Surging Today Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany.…
seekingalpha.com Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript
benzinga.com 5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR, Biofrontera And More Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
benzinga.com Why Are Biofrontera Shares Rising Today? Biofrontera Inc BFRI has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with…
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 88 companies set new 52-week lows.
seekingalpha.com Is Biofrontera Stock A Buy Or Sell? Several Catalysts In 2022 Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label…
benzinga.com What's Going On With Biofrontera Shares Today? Biofrontera Inc (NASDAQ:BFRI) is trading higher Tuesday on abnormally-high volume. The stock is seeing increased interest across social media platforms.
pulse2.com Biofrontera Stock (BFRI): Why The Price Surged Today The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 40% during intraday trading today. This is why it happened.
investorplace.com BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today Biofrontera (BFRI) stock is on the move today as traders take to Twitter (TWTR) to discuss the latest news surrounding the company. The post BFRI Stock Alert: The Social Media Chatter That Has…
benzinga.com Biofrontera Shares Are Trading Higher After Benchmark Initiates Coverage Benchmark initiated coverage of Biofrontera Inc (NASDAQ:BFRI) with a Buy rating and $11 price target. The Company specializes in medical dermatology, which recently came public in the U.S. as a…
investorplace.com Biofrontera Is Promising, But Could Be Limited by Competition and Volatility BFRI stock could rise on the company's treatment for actinic keratosis, which can lead to skin cancer, but it has hurdles to overcome first. The post Biofrontera Is Promising, But Could Be Limited by…
investorplace.com $20 Price Prediction Is Ambitious but Possible for Biofrontera BFRI stock is an imperfect investment as Biofrontera isn't currently profitable, but a new patent could provide a significant revenue source. The post $20 Price Prediction Is Ambitious but Possible…
pulse2.com Biofrontera (BFRI) Stock: Why The Price Surged Today The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 27% during intraday trading today. This is why it happened.
benzinga.com Why Are Biofrontera Shares Surging Today? The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Biofrontera Inc (NASDAQ: BFRI) titled "Illumination for Photodynamic Therapy." The patent covers…
investorplace.com BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office. The post BFRI Stock: The News That Has Biofrontera Shares Bounding…
seekingalpha.com Biofrontera's (BFRI) CEO Erica Monaco on Q3 2021 Results - Earnings Call Transcript Biofrontera's (BFRI) CEO Erica Monaco on Q3 2021 Results - Earnings Call Transcript
benzinga.com Earnings Scheduled For November 17, 2021 Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion.
benzinga.com Earnings Scheduled For May 11, 2021 Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com 56 Biggest Movers From Friday Gainers Nano-X Imaging Ltd. (NASDAQ: NNOX) shares gained 32.9% to close at $64.19. Nano X Imaging recently announced it has signed an agreement with SPI Medical for the deployment of 630 Nanox.ARC…
benzinga.com 76 Biggest Movers From Yesterday Gainers LMP Automotive Holdings, Inc. (NASDAQ: LMPX) shares surged 69.7% to close at $11.81 on Monday following Q2 results. The company’s earnings came in at $0.02 per share, while revenue jumped 44%…- benzinga.com 81 Biggest Movers From Yesterday Gainers
- benzinga.com Stocks That Hit 52-Week Lows On Thursday